Uramustine

Uramustine
Clinical data
ATC code
Pharmacokinetic data
Protein binding5%
ExcretionRenal
Identifiers
  • 5-[bis(2-Chloroethyl)amino]-1H-pyrimidine-2,4-dione
CAS Number
  • 66-75-1 checkY
PubChem CID
  • 6194
IUPHAR/BPS
  • 7621
DrugBank
  • DB00791 ☒N
ChemSpider
  • 5959 ☒N
UNII
  • W7KQ46GJ8U
KEGG
  • D06265 checkY
ChEMBL
  • ChEMBL1488 ☒N
CompTox Dashboard (EPA)
  • DTXSID8026270
ECHA InfoCard100.000.574
Chemical and physical data
FormulaC8H11Cl2N3O2
Molar mass252.10 g·mol−1
3D model (JSmol)
  • Interactive image
  • O=C1C(\N(CCCl)CCCl)=C/NC(=O)N1
  • InChI=1S/C8H11Cl2N3O2/c9-1-3-13(4-2-10)6-5-11-8(15)12-7(6)14/h5H,1-4H2,(H2,11,12,14,15) ☒N
  • Key:IDPUKCWIGUEADI-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Uramustine (INN) or uracil mustard is a chemotherapy drug which belongs to the class of alkylating agents.[1] It is used in lymphatic malignancies such as non-Hodgkin's lymphoma. It works by damaging DNA, primarily in cancer cells that preferentially take up the uracil due to their need to make nucleic acids during their rapid cycles of cell division. The DNA damage leads to apoptosis of the affected cells. Bone marrow suppression and nausea are the main side effects.

Chemically it is a derivative of nitrogen mustard and uracil.

References

  1. ^ Ghorani-Azam A, Balali-Mood M (2015). "Clinical pharmacology and toxicology of mustard compounds.". In Balali-Mood M, Abdollahi M (eds.). Basic and clinical toxicology of mustard compounds. Cham: Springer. p. 74. ISBN 978-3-319-23874-6.


Retrieved from "https://en.wikipedia.org/w/index.php?title=Uramustine&oldid=1147749686"